181 related articles for article (PubMed ID: 36301489)
1. CD155 is a putative therapeutic target in medulloblastoma.
Li S; McLendon R; Sankey E; Kornahrens R; Lyne AM; Cavalli FMG; McKay Z; Herndon JE; Remke M; Picard D; Gromeier M; Brown M; Thompson EM
Clin Transl Oncol; 2023 Mar; 25(3):696-705. PubMed ID: 36301489
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.
Thompson EM; Brown M; Dobrikova E; Ramaswamy V; Taylor MD; McLendon R; Sanks J; Chandramohan V; Bigner D; Gromeier M
J Neuropathol Exp Neurol; 2018 Aug; 77(8):696-702. PubMed ID: 29878245
[TBL] [Abstract][Full Text] [Related]
3. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
[TBL] [Abstract][Full Text] [Related]
4. Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma.
Thompson EM; Kang KD; Stevenson K; Zhang H; Gromeier M; Ashley D; Brown M; Friedman GK
Transl Oncol; 2024 Feb; 40():101875. PubMed ID: 38183802
[TBL] [Abstract][Full Text] [Related]
5. CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics.
Sloan KE; Stewart JK; Treloar AF; Matthews RT; Jay DG
Cancer Res; 2005 Dec; 65(23):10930-7. PubMed ID: 16322240
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
Murakami T; Takasawa A; Takasawa K; Akimoto T; Aoyama T; Magara K; Saito Y; Ota M; Kyuno D; Yamamoto S; Hasegawa T; Saito T; Osanai M
Cancer Sci; 2021 Feb; 112(2):906-917. PubMed ID: 33185939
[TBL] [Abstract][Full Text] [Related]
7. Complexes of poliovirus serotypes with their common cellular receptor, CD155.
He Y; Mueller S; Chipman PR; Bator CM; Peng X; Bowman VD; Mukhopadhyay S; Wimmer E; Kuhn RJ; Rossmann MG
J Virol; 2003 Apr; 77(8):4827-35. PubMed ID: 12663789
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus receptor CD155-targeted oncolysis of glioma.
Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
[TBL] [Abstract][Full Text] [Related]
9. Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.
Zhand S; Hosseini SM; Tabarraei A; Moradi A; Saeidi M
J Cancer Res Ther; 2019; 15(1):61-67. PubMed ID: 30880756
[TBL] [Abstract][Full Text] [Related]
10. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
Smazynski J; Hamilton PT; Thornton S; Milne K; Wouters MCA; Webb JR; Nelson BH
Gynecol Oncol; 2020 Jul; 158(1):167-177. PubMed ID: 32446718
[TBL] [Abstract][Full Text] [Related]
11. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration.
Sloan KE; Eustace BK; Stewart JK; Zehetmeier C; Torella C; Simeone M; Roy JE; Unger C; Louis DN; Ilag LL; Jay DG
BMC Cancer; 2004 Oct; 4():73. PubMed ID: 15471548
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Glioblastoma Treated with Recombinant Poliovirus.
Desjardins A; Gromeier M; Herndon JE; Beaubier N; Bolognesi DP; Friedman AH; Friedman HS; McSherry F; Muscat AM; Nair S; Peters KB; Randazzo D; Sampson JH; Vlahovic G; Harrison WT; McLendon RE; Ashley D; Bigner DD
N Engl J Med; 2018 Jul; 379(2):150-161. PubMed ID: 29943666
[TBL] [Abstract][Full Text] [Related]
13. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?
Maherally Z; Smith JR; An Q; Pilkington GJ
PLoS One; 2012; 7(2):e30691. PubMed ID: 22363471
[TBL] [Abstract][Full Text] [Related]
14. Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS.
Yang Y; Brown MC; Zhang G; Stevenson K; Mohme M; Kornahrens R; Bigner DD; Ashley DM; López GY; Gromeier M
Neuro Oncol; 2023 Sep; 25(9):1631-1643. PubMed ID: 36864784
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
17. MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.
Yogi K; Sridhar E; Goel N; Jalali R; Goel A; Moiyadi A; Thorat R; Panwalkar P; Khire A; Dasgupta A; Shetty P; Shirsat NV
Oncoscience; 2015; 2(4):334-48. PubMed ID: 26097868
[TBL] [Abstract][Full Text] [Related]
18. G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.
Whittier KL; Boese EA; Gibson-Corley KN; Kirby PA; Darbro BW; Qian Q; Ingram WJ; Robertson T; Remke M; Taylor MD; O'Dorisio MS
Acta Neuropathol Commun; 2013 Oct; 1():66. PubMed ID: 24252460
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.
Beasley GM; Nair SK; Farrow NE; Landa K; Selim MA; Wiggs CA; Jung SH; Bigner DD; True Kelly A; Gromeier M; Salama AK
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33875611
[TBL] [Abstract][Full Text] [Related]
20. Rapid diagnosis of medulloblastoma molecular subgroups.
Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
